{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:34:24Z","timestamp":1793180064188,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,19]],"date-time":"2013-01-19T00:00:00Z","timestamp":1358553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00428-013-1372-x","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T03:24:07Z","timestamp":1358479447000},"page":"349-354","source":"Crossref","is-referenced-by-count":8,"title":["Nuclear factor-\u03baB activation in primary lymphoma of bone"],"prefix":"10.1007","volume":"462","author":[{"given":"Lianne","family":"Koens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenna H.","family":"Heyning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gota","family":"Szepesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Matolcsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pancras C. W.","family":"Hogendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,19]]},"reference":[{"key":"1372_CR1","first-page":"306","volume-title":"World Health Classification of tumours: Pathology amd genetics of tumours of soft tissue and bone","author":"KK Unni","year":"2002","unstructured":"Unni KK, Hogendoorn PC (2002) Malignant lymphoma. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Classification of tumours: Pathology amd genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 306\u2013308"},{"issue":"12","key":"1372_CR2","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","volume":"23","author":"A Lopez-Guillermo","year":"2005","unstructured":"Lopez-Guillermo A, Colomo L, Jimenez M et al (2005) Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 23(12):2797\u20132804","journal-title":"J Clin Oncol"},{"issue":"10","key":"1372_CR3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00256-007-0335-1","volume":"36","author":"FH Heyning","year":"2007","unstructured":"Heyning FH, Kroon HM, Hogendoorn PC, Taminiau AH, van der Woude HJ (2007) MR imaging characteristics in primary lymphoma of bone with emphasis on non-aggressive appearance. Skeletal Radiol 36(10):937\u2013944","journal-title":"Skeletal Radiol"},{"issue":"12","key":"1372_CR4","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/cncr.21930","volume":"106","author":"K Beal","year":"2006","unstructured":"Beal K, Allen L, Yahalom J (2006) Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer 106(12):2652\u20132656","journal-title":"Cancer"},{"issue":"12","key":"1372_CR5","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/sj.leu.2401582","volume":"13","author":"FH Heyning","year":"1999","unstructured":"Heyning FH, Hogendoorn PC, Kramer MH et al (1999) Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 13(12):2094\u20132098","journal-title":"Leukemia"},{"issue":"9","key":"1372_CR6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jcp.2008.063156","volume":"62","author":"FH Heyning","year":"2009","unstructured":"Heyning FH, Hogendoorn PC, Kramer MH, Holland CT, Dreef E, Jansen PM (2009) Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype. J Clin Pathol 62(9):820\u2013824","journal-title":"J Clin Pathol"},{"issue":"9","key":"1372_CR7","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.humpath.2008.01.004","volume":"39","author":"H Adams","year":"2008","unstructured":"Adams H, Tzankov A, d\u2019Hondt S, Jundt G, Dirnhofer S, Went P (2008) Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors. Hum Pathol 39(9):1323\u20131330","journal-title":"Hum Pathol"},{"issue":"9","key":"1372_CR8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00000478-200309000-00011","volume":"27","author":"L Leval de","year":"2003","unstructured":"de Leval L, Braaten KM, Ancukiewicz M, Kiggundu E, Delaney T, Mankin HJ, Harris NL (2003) Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 27(9):1269\u20131277","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1372_CR9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/PAS.0b013e3181b314ce","volume":"33","author":"S Bhagavathi","year":"2009","unstructured":"Bhagavathi S, Micale MA, Les K, Wilson JD, Wiggins ML, Fu K (2009) Primary bone diffuse large B-cell lymphoma: clinicopathologic study of 21 cases and review of literature. Am J Surg Pathol 33(10):1463\u20131469","journal-title":"Am J Surg Pathol"},{"key":"1372_CR10","doi-asserted-by":"crossref","unstructured":"Heyning FH, Jansen PM, Hogendoorn PC, Szuhai K (2010) Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone. J Clin Pathol 63(12):1095\u20131100","DOI":"10.1136\/jcp.2010.078915"},{"issue":"7247","key":"1372_CR11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","volume":"459","author":"M Compagno","year":"2009","unstructured":"Compagno M, Lim WK, Grunn A et al (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459(7247):717\u2013721","journal-title":"Nature"},{"issue":"12","key":"1372_CR12","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","volume":"194","author":"RE Davis","year":"2001","unstructured":"Davis RE, Brown KD, Siebenlist U, Staudt LM (2001) Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194(12):1861\u20131874","journal-title":"J Exp Med"},{"issue":"7089","key":"1372_CR13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","volume":"441","author":"VN Ngo","year":"2006","unstructured":"Ngo VN, Davis RE, Lamy L et al (2006) A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441(7089):106\u2013110","journal-title":"Nature"},{"issue":"1","key":"1372_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.28.11.1","volume":"11","author":"LT Lam","year":"2005","unstructured":"Lam LT, Davis RE, Pierce J et al (2005) Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res 11(1):28\u201340","journal-title":"Clin Cancer Res"},{"key":"1372_CR15","first-page":"179","volume-title":"World Health Organisation classification of tumours of haematopoietic and lymphoid tissues","author":"NL Harris","year":"2008","unstructured":"Harris NL (2008) Mature B-cell neoplasms. In: Swerdlow SH, Campo E, Harris NL et al (eds) World Health Organisation classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 179\u2013267"},{"issue":"17","key":"1372_CR16","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"WW Choi","year":"2009","unstructured":"Choi WW, Weisenburger DD, Greiner TC et al (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15(17):5494\u20135502","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1372_CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.jnen.0000248553.45456.96","volume":"66","author":"C Courts","year":"2007","unstructured":"Courts C, Montesinos-Rongen M, Martin-Subero JI et al (2007) Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression. J Neuropathol Exp Neurol 66(3):230\u2013237","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1372_CR18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12308-009-0021-4","volume":"2","author":"CV Curry","year":"2009","unstructured":"Curry CV, Ewton AA, Olsen RJ et al (2009) Prognostic impact of C-REL expression in diffuse large B-cell lymphoma. J Hematop 2(1):20\u201326","journal-title":"J Hematop"},{"issue":"22","key":"1372_CR19","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1182\/blood-2012-05-428466","volume":"120","author":"M Gupta","year":"2012","unstructured":"Gupta M, Maurer MJ, Wellik LE et al (2012) Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab\/R-CHOP. Blood 120(22):4400\u20134406","journal-title":"Blood"},{"issue":"1","key":"1372_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282","journal-title":"Blood"},{"issue":"1","key":"1372_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8(1):49\u201362","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"1372_CR22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2008.07.003","volume":"29","author":"SC Sun","year":"2008","unstructured":"Sun SC, Ley SC (2008) New insights into NF-kappaB regulation and function. Trends Immunol 29(10):469\u2013478","journal-title":"Trends Immunol"},{"issue":"1","key":"1372_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","volume":"8","author":"V Baud","year":"2009","unstructured":"Baud V, Karin M (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8(1):33\u201340","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1372_CR24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2559.2008.03139.x","volume":"53","author":"I Espinosa","year":"2008","unstructured":"Espinosa I, Briones J, Bordes R et al (2008) Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications. Histopathology 53(4):441\u2013449","journal-title":"Histopathology"},{"issue":"5","key":"1372_CR25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/DAD.0b013e3181c1195b","volume":"32","author":"S Bhagavathi","year":"2010","unstructured":"Bhagavathi S, Blenc AM, Amin M et al (2010) Primary cutaneous large B-cell lymphoma shows activation of nuclear factor kappa B and low incidence of Epstein\u2013Barr virus. Am J Dermatopathol 32(5):439\u2013441","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"1372_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","volume":"107","author":"AS Baldwin","year":"2001","unstructured":"Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107(3):241\u2013246","journal-title":"J Clin Invest"},{"issue":"24","key":"1372_CR27","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","volume":"113","author":"K Dunleavy","year":"2009","unstructured":"Dunleavy K, Pittaluga S, Czuczman MS (2009) Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 113(24):6069\u20136076","journal-title":"Blood"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-013-1372-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1372-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T19:33:25Z","timestamp":1687980805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-013-1372-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,19]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s00428-013-1372-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,19]]}}}